文献速递心律失常瓣膜病与结构性心脏病

Brugada综合征:诊断、病理生理与管理的更新与未来展望

Brugada syndrome: update and future perspectives.
PubMed 文献 · Heart · 2021-10-14

本文综述Brugada综合征(BrS)的诊断、病理生理和管理进展。BrS以典型心电图表现和心律失常/心源性猝死(SCD)风险增高为特征,无症状患者占新诊断多数且随家族筛查预计增多。风险分层仍具挑战,近期研究显示风险评分有助于识别高危患者,整合临床与遗传等因素的模型有望改善预测并指导管理。

要点

  • 无症状患者占BrS新诊断多数,家族筛查将增加检出。
  • 风险分层困难,尤其无症状者,风险评分有助识别高危。
  • 整合临床、遗传、共病、年龄性别与环境因素的模型待开发验证。

核心结论

  • BrS诊断与心律失常风险预测仍具挑战,尤其无症状患者。
  • 风险评分有助于识别心律失常和SCD高危患者。
  • 整合临床与遗传等因素的模型可能改善疾病表达与风险预测并指导管理。

研究设计与样本

  • 综述,总结BrS诊断、病理生理与管理进展及未来展望。

主要发现

  • 无症状患者占新诊断BrS多数,发病率随家族筛查预计上升。
  • 遗传与分子病理生理理解受限于缺乏真正金标准,临床定义共识随时间变化。
  • 研究日益认识到潜在结构基质的相关性。
  • 近期研究显示风险评分可识别心律失常和SCD高危患者。

临床怎么用

  • 对BrS患者应关注无症状者的风险分层。
  • 可考虑使用风险评分辅助识别心律失常和SCD高危患者。
  • 管理决策可参考整合临床与遗传等因素的预测模型(待验证)。

局限性

  • 缺乏真正金标准,临床定义共识随时间变化。
  • 无症状患者风险分层仍具挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Brugada syndrome (BrS) is an inherited cardiac disorder, characterised by a typical ECG pattern and an increased risk of arrhythmias and sudden cardiac death (SCD). BrS is a challenging entity, in regard to diagnosis as well as arrhythmia risk prediction and management. Nowadays, asymptomatic patients represent the majority of newly diagnosed patients with BrS, and its incidence is expected to rise due to (genetic) family screening. Progress in our understanding of the genetic and molecular pathophysiology is limited by the absence of a true gold standard, with consensus on its clinical definition changing over time. Nevertheless, novel insights continue to arise from detailed and in-depth studies, including the complex genetic and molecular basis. This includes the increasingly recognised relevance of an underlying structural substrate. Risk stratification in patients with BrS remains challenging, particularly in those who are asymptomatic, but recent studies have demonstrated the potential usefulness of risk scores to identify patients at high risk of arrhythmia and SCD. Development and validation of a model that incorporates clinical and genetic factors, comorbidities, age and gender, and environmental aspects may facilitate improved prediction of disease expressivity and arrhythmia/SCD risk, and potentially guide patient management and therapy. This review provides an update of the diagnosis, pathophysiology and management of BrS, and discusses its future perspectives.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Marsman EMJ, Postema PG, Remme CA, et al. Brugada syndrome: update and future perspectives. Heart. 2021. PMID: 34649929. doi:10.1136/heartjnl-2020-318258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。